Year :
2024
| Month :
April
| Volume :
18
| Issue :
4
| Page :
OC05 - OC09
Clinical Profile of Post-COVID-19 Patients with Persistent Chest Pain: A Cross-sectional Study
Sibaram Panda, Sunil Kumar Sharma, Jagannath Hati, Braja Bihari Panda
1. Assistant Professor, Department of Cardiology, VIMSAR, Sambalpur, Odisha, India.
2. Professor and Head, Department of Cardiology, VIMSAR, Sambalpur, Odisha, India.
3. Assistant Professor, Department of General Medicine, VIMSAR, Sambalpur, Odisha, India.
4. Professor and Head, Department of Radiology, VIMSAR, Sambalpur, Odisha, India.
Correspondence Address :
Dr. Sibaram Panda,
Doctor Colony, Burla, Sambalpur-768017, Odisha, India.
E-mail: drsibaram@gmail.com
Abstract
Introduction: Chest pain in post-COVID-19 patients can be due to serious alarming post-COVID-19 sequelae, such as Coronary Artery Disease (CAD), pulmonary embolism, myocarditis, etc. Approximately one-fifth of patients attending clinical Outpatient Department (OPD) following COVID-19 recovery present with persistent chest pain. There is limited knowledge about the clinical profile of patients experiencing persistent post-COVID-19 chest pain.
Aim: To describe the clinical profile of such patients to fill the knowledge gap and acquire new insights into patients with post-COVID-19 persistent chest pain.
Materials and Methods: A cross-sectional study was conducted, enrolling a total of 259 patients with persistent chest pain (i.e., chest pain lasting more than 24 weeks after COVID-19 diagnosis). After detailed history-taking and clinical and laboratory examinations, observed data were collected, compiled, evaluated, and analysed to achieve the study objectives.
Results: Out of 259 patients, 133 (51.4%) had cardiac {85 (32.8%)} or pulmonary {48 (18.5%)} abnormalities. Among patients with cardiac abnormalities, CAD, arrhythmia, myocarditis/cardiomyopathy, pericarditis, and PAH were detected in 38 (14.6%), 18 (6.9%), 7 (2.7%), 11 (4.2%), and 11 (4.2%), respectively. Meanwhile, among patients with pulmonary abnormalities, 36 (13.9%) patients had organic residual lesions in the lung parenchyma, 7 (2.7%) had pleuritis, and 28 (10.8%) had pulmonary function abnormalities. The remaining 126 (48.6%) patients experienced chest pain due to non cardiopulmonary aetiologies like gastrointestinal {45 (17.3%)}, musculoskeletal {38 (14.6%)}, psychomotor {35 (13.5%)}, autonomic {8 (3.3%)}, etc.
Conclusion: This study found that chest pain in post-COVID-19 patients arises due to multisystemic aetiologies such as cardiac, pulmonary, visceral, autonomic, psychomotor, musculoskeletal, etc. A wide spectrum of serious cardiac abnormalities (such as CAD, arrhythmia, myocarditis, pericarditis, PAH, etc.) contributes to about 1/3rd of cases of persistent chest pain in post-COVID-19 patients.
Keywords
Chestpain, Multisystemic, Sequele
DOI and Others
DOI: 10.7860/JCDR/2024/65440.19259
Date of Submission: May 17, 2023
Date of Peer Review: Jul 01, 2023
Date of Acceptance: Jan 30, 2024
Date of Publishing: Apr 01, 2024
AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. Yes
PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: May 18, 2023
• Manual Googling: Jul 13, 2023
• iThenticate Software: Jan 27, 2024 (4%)
ETYMOLOGY: Author Origin
EMENDATIONS: 8
|